the clinical findings were typical of uveal melanoma. Immunoscintigraphy was positive in all five cases. In a further five patients there was doubt about the diagnosis. One was thought to have a choroidal haemangioma but failed to respond to treatment and immunoscintigraphy was positive, suggesting a diagnosis of melanoma. Two patients were assigned a diagnosis of choroidal haemangioma, one of melanocytoma or possible retinal pigment epithelium carcinoma, and one of metastasis. Immunoscintigraphy was negative in all these four cases. In combination with established diagnostic tests immunoscintigraphy may have a part to play in differentiating uveal melanoma from other similar tumours.
Malignant melanoma is the most frequently encountered primary intraocular neoplasm. Improved standards of eye care have resulted in more frequent discovery of asymptomatic lesions. These can be detected so early in their natural history that it may be difficult to distinguish between a small melanoma and a large choroidal naevus. A small symptomatic melanoma in turn may be similar in appearance to a choroidal haemangioma or a choroidal metastasis, particularly when relatively amelanotic. Because of the hazards of biopsy within the eye the ophthalmologist must differentiate between these lesions on clinical grounds aided by special investigations.
At present both radical and conservative options for treatment of uveal malignant melanoma rest largely on a clinical diagnosis. When Nuclear medicine has added a new dimension for localising tumours in the last decade by means of radiolabelled monoclonal antibodies (MoAb) against tumour associated antigens for diagnostic and therapeutic purposes.'4 This study follows preliminary invitro work with monoclonal antibodies (MoAb) raised against cutaneous melanoma to recognise 651 antigenic similarity in ocular melanomas. '6 The results were sufficiently encouraging to proceed to the use of these antibodies in vivo. It has been established that F(ab')2 fragments are more effective for radioimmunodetection than whole MoAb, since non-specific uptake by the spleen, liver, and bone marrow is reduced and they are more rapidly cleared from the blood.'6 Comparative studies on biodistribution of F(ab')2 fragments with different radioisotopes ("3'I, '3I, "'In, and n'"Tc) indicate that 99"11TC-F(ab')2 fragments are the most suitable for radioimmunoscintigraphy when there is rapid tumour uptake, because of the high signal generated from the target through the injection of a high activity short-lived radionuclide (half life of 6 h). ' The antibody was provided in the form of an instant labelling kit Technemab-K-1 of Sorin Biomedica. Labelling was carried out by the addition of sterile '-Tc pertechnetate to a lyophilised preparation containing 350~tg of F(ab')2 fragments of MoAb 225.28S, which is against a high molecular weightmelanoma associated antigen (HMW-MAA). After thorough mixing the solution was incubated for 15 minutes at room temperature. Free '""Tc was then removed by ion exchange column chromatography through sterile pyrogen free DEAE-Sephadex A25. This method gave 85-90'%o labelling, and residual free "'Tc was <5%. The labelled preparation was injected within one hour of being prepared. IMAGING 
PROTOCOL
Prior to the study the procedure was explained to the patient and written informed consent obtained in each case. Before the intravenous injection of labelled antibodies the patient's skin was tested for hypersensitivity to mouse immunoglobulins. No reaction was noted in any patient. 400 mg of potassium perchlorate was given orally 30 minutes prior to the injection to block the thyroid. A large field of view gamma camera (GE 400AT) with a general purpose collimator and an on-line computer (DEC Gamma 1) was used. The patient was placed supine with head fixed in a foam support. The camera was placed over the head in the anterior Waters view (caudal tilt of 15-30(). This position was chosen for the head to optimise separation of the orbits from interfering background, such as the nasal cavity and paranasal sinuses. An 18 gauge cannula was placed in an antecubital vein connected to a three-way stopcock. Between 340 and 370 MBq of ""Tc F(ab')2 was placed through the three-way stopcock and flushed with 20 ml of 0(9% normal saline. Dynamic images were acquired on a 64x64 matrix on the computer at a frame rate of 1 second/frame for 60 frames followed by 30 s/frame for 18 frames with the camera placed over the head in the anterior Waters view. Static images were acquired on a 128x 128 matrix on the computer with the camera over the head, chest, and pelvis for 400 000 counts each at 20 minutes, 1 h, 3 h, 5 h, and 6 h. Patient 2 was a 35-year-old Asian male with a large ciliochoroidal melanoma in his right eye measuring 13 mm in maximum diameter and 9 mm in thickness and situated temporally. Immunoscintigraphy was strongly positive for the right eye but was also weakly so for the left ( Table 1 ). The right eye was enucleated, and histopathology of the specimen showed a heavily pigmented, mixed cell melanoma arising in the ciliary body. The patient had heavily pigmented fundi, but a possible flat choroidal naevus was identified in the left eye.
Patient 3 was a 43-year-old white female with a small, lightly pigmented malignant melanoma measuring 7 mm in maximum diameter and 3 mm in thickness and situated above the left macula. Growth of the lesion had been recorded photographically. melanoma and conservative treatment was undertaken with "'Ru scleral plaque.
Patient 7 was a 69-year-old white female with a non-pigmented mass nasal to the right optic disc considered by the referring ophthalmologist to be an amelanotic malignant melanoma (Fig. 3) . The lesion measured 7 mm in maximum diameter and 2 mm in thickness on ultrasound. Fluorescein angiography showed very early, uniform (Fig. 4a) , and subsequently intense (Fig. 4b) choroidal filling which was more suggestive of a choroidal haemangioma. Immunoscintigraphy showed a vascular blush in the involved eye on the initial dynamic images but the static images were negative (Fig. lb) . The diagnosis was revised to choroidal haemangioma, and treatment by laser photocoagulation was instituted.
Patient 8 was a 70-year-old white female with an extremely heavily pigmented mass arising just above and partially obscuring the right optic disc (Fig. 5) . The maximum diameter of the lesion was 12 mm and it was 6 mm thick. Ultrasound also suggested that there was superficial invasion of the optic nerve. The differential diagnosis was considered to be between a melanocytoma, a juxtapapillary melanoma, and a carcinoma of the retinal pigment epithelium. Immunoscintigraphy was negative (Fig. 1c) , and management was by serial observation with photography and ultrasound.
Patient 9 was a 53-year-old white male with a pale lesion at the superior margin of the left optic disc (Fig. 6) . The tumour measured 9 mm in maximum diameter by 2 mm in thickness. Fluorescein fundus angiography was equivocal for a choroidal haemangioma or a melanoma. Immunoscintigraphy was negative. A diagnosis of choroidal haemangioma was made. There was no associated serous retinal detachment, and management was by serial observation with photography and ultrasound.
Patient JO was a 45-year-old white male with a pale lesion immediately temporal to the right macula measuring 7 mm in maximum diameter and 3 mm in thickness (Fig. 7) . Fluorescein angiography was atypical of a choroidal haemangioma and the differential diagnosis lay between an amelanotic melanoma and a metastasis. Immunoscintigraphy was negative (Fig. 8) . The patient, a non-smoker, was clinically well, but a small opacity was seen at the right hilum on plain chest x-ray, and subsequently a cystic lesion was demonstrated on CT. Bronchoscopic biopsy showed an adenocarcinoma.
The best scintigraphic images for tumour detection were obtained between 3 h and 6 h after injection (Fig. 2b) ; during this time interval the tumour/ background ratio was highest. In some cases the tumour was visualised at 1 h after injection. The nasal cavity, heart, liver, kidneys, and bladder were visualised in all cases on the static images. In three patients some splenic uptake were also noted. Maximum uptake was seen in the kidneys. In two cases, patients 1 and 4, cell impressions of the resected tumour were obtained. These were subjected to immunofluorescence staining; both specimens also gave a strong positive immunofluorescence with MoAb 225.28S in vitro.
Discussion
The HMW-MAA is a combination of two noncovalently associated glycopolypeptides. One The use of an antibody raised against cutaneous melanoma for imaging ocular melanomas is potentially specific. It has been shown that the ocular melanomas have some similarity to the cutaneous melanomas in their antigenic features.'5 This sharing of antigenicity can be used for diagnostic purposes. The specificity for radioimmunoscintigraphy procedures as a whole is high. However, the sensitivity varies in accordance with the tumour size, lesion site, and the rate and amount of antibody uptake. In this study we had one false positive result in patient 2. This may have resulted from the presence of a naevus in the second eye, and the immunoscintigraphic response of the choroidal naevi remains to be investigated. As with any diagnostic imaging test for tumours, the possibility of a false negative or false positive result is always present, but it is hoped that this test will ultimately supplement and complement other established diagnostic tests and help the ophthalmic surgeon in the management of patients with ocular tumours.
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